Biogen Inc (BIIB.xnas)

traders view logo Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Biogen Inc (BIIB.xnas) Profile

Biogen Inc (BIIB.xnas) is a multinational biotechnology company and pioneers in neuroscience headquartered in Massachusetts, America. Biogen specialises in the discovery, development, and delivery of therapies to treat neurological diseases to patients globally with marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA, FUMADERM and SPINRAZA. Biogen is the first company that FDA approved Biogen’s Alzheimer’s disease drug aducanumab, which U.S. regulators cleared to slow cognitive decline in people living with the disease. Biogen is one of the world’s first global biotechnology companies aiming the last decade to defeat devastating neurological diseases with 38 office locations across 33 countries. The company operates outside of the United States, across Europe, Canada, Latin America, the Middle East and the Asia Pacific and employs 9.100 people. Biogen has a network of distribution partners in over 50 additional countries with 42 subsidiaries and a $13.4B (USD) in 2020 yearly revenue. The Biogen Inc stock (BIIB.xnas) is traded on the NASDAQ and has a market capitalisation of $32.92B (USD) as of December 2021. The U.S regulators approved Biogen’s aducanumab drug to treat Alzheimer in June 2021 with the price of $56,000 (USD) per year.

Holding cost
Trading hours in US Eastern Time

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

Why Trade Biogen Inc (BIIB.xnas) with FP Markets? An Australian-regulated forex & CFD broker
go long or short
Go Long or Short

Increase your ability to profit in
all market conditions
Leverage options up to 20:1

direct market access
Direct Market Access (DMA) Execution

Real-time, transparent share prices
Control, Functionality and deep liquidity
Full Market depth & see your orders in the queue

advanced platforms
Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with
superior client portal

24/5 Multilingual customer support
24/5 Multilingual
Customer Support

Award winning support &
personal account managers

global exposure
Global Exposure

Low margins and competitive commission
+10,000 products on global stocks
across 4 continents

earn dividends
Earn Dividends

On long positions
No ownership of physical
shares necessary

Start Trading
in Minutes

bullet Access 10,000+ financial instruments
bullet Auto open & close positions
bullet News & economic calendar
bullet Technical indicators & charts
bullet Many more tools included

By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.

Source - cache | Page ID - 621

Get instant Updates in Telegram